2nd July 2015
Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")
Top Ten Equity Holdings and Sector Exposure as at 30- June- 15 and full Portfolio listing as at 29-May-15 available from company's website
Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 30st June 2015 the top ten equity holdings and the sector breakdown were as follows:
Top 10 Holdings |
% |
Pfizer |
8.2% |
Novartis |
7.9% |
Eli Lilly & Co |
7.1% |
Roche |
6.4% |
Johnson & Johnson |
5.0% |
AstraZeneca |
4.5% |
AbbVie |
3.8% |
Merck & Co |
3.6% |
Sanofi |
3.6% |
Astellas Pharma |
3.5% |
Total |
53.5% |
Sector Exposure |
% |
Pharmaceuticals |
66.8% |
Healthcare Equipment |
8.9% |
Healthcare Facilities |
5.4% |
Biotechnology |
4.2% |
Healthcare REITs |
4.0% |
Healthcare Services |
2.5% |
Life Sciences Tools & Services |
1.3% |
Healthcare Distributors |
1.2% |
Healthcare Supplies |
0.7% |
Healthcare Technology |
0.4% |
Life & Health Insurance |
0.4% |
Managed Healthcare |
0.2% |
Multi-line Insurance |
0.0% |
Cash |
3.8% |
Total |
100.0 |
|
|
The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager. www.Polarcapitalhealthcaretrust.com
Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.